Our previous work introduced nucleotide-based KRAS G13C inhibitors featuring a linker and acrylamide moiety, specifically targeting this mutation 34
The majority are minor, but awareness of them assists patients in making informed decisions
Studies show many people begin to see noticeable weight loss within the first few weeks, but losing 20 pounds can take anywhere from a couple of months to several months with consistent use
Angling the needle during withdrawal tears a wider track through the tissue, which increases bruising, leaking, and post-injection soreness
Certain patients using tirzepatide may discuss split dosing with their provider to improve tolerability or reduce medication wear-off symptoms
Gastrointestinal symptoms are the most frequently reported issues, with nausea being the most common